US Will Work Closely With "Great Ally" India: Trump Administration

Agencies
May 29, 2019

Washington, May 29: India is a "great ally" of America and the US will continue to work closely with Prime Minister Narendra Modi, the Trump administration has said, asserting that Secretary of State Mike Pompeo was looking forward to have a "robust discussion" with his Indian counterpart on a wide range of issues.

State Department Spokesperson Morgan Ortagus told reporters during an off-camera news conference here on Tuesday that the US was confident in the fairness and integrity of the just-concluded general elections in India.

The Trump administration, including President Donald Trump, Vice President Mike Pence and Mr Pompeo, congratulated PM Modi and his Bharatiya Janata Party on the spectacular electoral victory in the Lok Sabha elections whose results were declared on May 23.

"We, of course, will work closely with Modi, as we have many times," Mr Ortagus told reporters in response to a question.

"We''re confident in the fairness and integrity of the elections, and I think that Secretary Pompeo will have a very robust discussion on a range of issues. India is a great ally and partner of the United States," Mr Ortagus said.

The US Lawmakers and senior government officials continue to congratulate PM Modi on his grand electoral victory.

Indian-Americans organised victory celebrations in various parts of the US. Several more are in the pipeline on a large scale in the coming weeks.

According to a compilation made by the Indian Embassy here, more than 50 Congressmen, Senators and the senior government officials have sent congratulatory messages to PM Modi.

"India continues to have amazing potential and is a strong US partner. Congratulations to Narendra Modi on your success with the elections and the direction you are taking India. We look forward to seeing our partnership continue to strengthen," tweeted Indian-American politician Nikki Haley.

"Congratulations to Modi ''on being re-elected'' as Prime Minister of India, said Congressman Al Green.

"I wish peace and prosperity for India and its neighbours and look forward to seeing you at India House in my congressional district in Houston, Texas, USA," he said.

In the first back-to-back majority for a single party in over three decades, the Modi-led Bharatiya Janata Party won 303 out of the total 542 Lok Sabha seats, handing out a crushing defeat to the Congress Party and many other political opponents.

"Prime Minister Modi has led India and has brought lot of credibility in foreign affairs and made India a power to reckon with. He has travelled all the continents and made friends and has a given the prestige to India that was long overdue," said Sampat Shivangi, president of Indian American Forum.

"India is a no more a third world country and has stood the test of time and has been recognised as one of the top six economies in the world," Mr Shivangi said.

The Indian-Americans will put pressure and use the political clout to impress upon the US the importance of a balanced and fair trade agreement with India.

"We do not want another impasse as we see with US-China trade and we do not want India to be another China," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

Kuala Lumpur, Feb 4: Malaysia said on Tuesday that India's move to cut back on palm oil purchases is "temporary" and will be resolved amicably between the two nations.

Last month, India restricted imports of refined palm oil and asked importers to avoid purchases from Malaysia after its criticism of actions in Kashmir and a new citizenship law.

"Having long-standing bilateral ties, the two nations will overcome the current challenges, and prevail towards mutual and beneficial outcomes," the Malaysian Palm Oil Council said in a statement, citing Primary Industries Minister Teresa Kok.

Malaysia's push to implement B20 biodiesel starting this month will also help sustain high crude palm oil prices, the statement read.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 22,2020

Washington, Feb 22: US President Donald Trump will raise the issue of religious freedom with Prime Minister Narendra Modi during his visit to India next week, the White House said on Friday, noting that the US has great respect for India's democratic traditions and institutions.

"President Trump will talk about our shared tradition of democracy and religious freedom both in his public remarks and then certainly in private. He will raise these issues, particularly the religious freedom issue, which is extremely important to this administration," a senior official told reporters in a conference call.

The official was responding to a question on whether the president was planning to speak to Modi on the Citizenship (Amendment) Act or the National Register of Citizens.

"We do have this shared commitment to upholding our universal values, the rule of law. We have great respect for India's democratic traditions and institutions, and we will continue to encourage India to uphold those traditions," the official said, requesting anonymity.

"And we are concerned with some of the issues that you have raised," the senior administration official said, in response to the question on CAA and NRC.

"I think the President will talk about these issues in his meetings with Prime Minister Modi and note that the world is looking to India to continue to uphold its democratic traditions, respect for religious minorities," the official said.

"Of course, it's in the Indian constitution -- religious freedom, respect for religious minorities, and equal treatment of all religions. So this is something that is important to the president and I'm sure it will come up," said the official.

Pointing out that India has a strong democratic foundation, the official said India is a country rich in religious, linguistic, and cultural diversity.

"In fact, it's the birthplace of four major world religions," the official noted.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.